Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.300 | Biomarker | disease | CTD_human | Reduced sarcoplasmic reticulum Ca2+ -ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium. | 16317512 | 2006 | ||||
|
0.300 | Biomarker | disease | CTD_human | Reduced sarcoplasmic reticulum Ca2+ -ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium. | 16317512 | 2006 | ||||
|
0.300 | Biomarker | disease | CTD_human | Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans. | 11927517 | 2002 | ||||
|
0.300 | Biomarker | disease | CTD_human | Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans. | 11927517 | 2002 | ||||
|
0.020 | Biomarker | disease | BEFREE | The precise mechanism of cardiac troponin I (cTnI) proteolysis in myocardial stunning is not fully understood. | 18378675 | 2008 | ||||
|
0.020 | Biomarker | disease | LHGDN | C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force: implications for the pathophysiology of myocardial stunning. | 14551240 | 2003 | ||||
|
0.020 | Biomarker | disease | BEFREE | C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force: implications for the pathophysiology of myocardial stunning. | 14551240 | 2003 | ||||
|
0.010 | Biomarker | disease | BEFREE | The results demonstrate that in vivo gene transfer of the cDNA encoding Ec-SOD provides the heart with substantial protection against myocardial stunning without the need for concomitant administration of catalase. | 9760299 | 1998 |